Biogen Shares Up Following Eli Lilly's Failed Alzheimer's Study

Biogen Shares Up Following Eli Lilly's Failed Alzheimer's Study

3 Hot and Undervalued Biotechs That Are Immune to Trump's Threats

3 Hot and Undervalued Biotechs That Are Immune to Trump's Threats

3 Successful Start-Ups That Shun the Spotlight

3 Successful Start-Ups That Shun the Spotlight

Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results

Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results

Don't Give Up on Battered Teva Stock; a Turnaround Is Coming

Don't Give Up on Battered Teva Stock; a Turnaround Is Coming

Biogen Shares Spike on Leaked Alzheimer's Drug Data

Biogen Shares Spike on Leaked Alzheimer's Drug Data

Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016

Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016

Voyager Therapeutics' Gene Therapy Shows Early, Promising Results

Voyager Therapeutics' Gene Therapy Shows Early, Promising Results

Biotechs Bolstered on 21st Century Cures Passage

Biotechs Bolstered on 21st Century Cures Passage

Trump Presidency Could Offer New Challenges for Shaky Drug Sector

Trump Presidency Could Offer New Challenges for Shaky Drug Sector